XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.2
EPS Calculation (Tables)
6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS
The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and six months ended June 30, 2019 and 2018:
 
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
(In Thousands, Except Per Share Amounts)
 
2019
 
2018
 
2019
 
2018
Basic EPS:
 
 
 
 
 
 
 
 
Net income to common stockholders
 
$
93,040

 
$
70,395

 
$
181,897

 
$
153,790

Dividends declared on preferred stock
 
(3,750
)
 
(3,750
)
 
(7,500
)
 
(7,500
)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities
 
(276
)
 
(241
)
 
(532
)
 
(460
)
Net income to common stockholders - basic
 
$
89,014

 
$
66,404

 
$
173,865

 
$
145,830

Basic weighted average common shares outstanding
 
450,538

 
398,478

 
450,449

 
398,398

Basic EPS
 
$
0.20

 
$
0.17

 
$
0.39

 
$
0.36

 
 
 
 
 
 
 
 
 
Diluted EPS:
 
 
 
 
 
 
 
 
Net income to common stockholders - basic
 
89,014

 
66,404

 
173,865

 
145,830

Interest expense on Convertible Senior Notes
 
1,206

 

 
1,206

 

Net income to common stockholders - diluted
 
$
90,220

 
$
66,404

 
$
175,071

 
$
145,830

Basic weighted average common shares outstanding
 
450,538

 
398,478

 
450,449

 
398,398

Effect of assumed Convertible Senior Notes conversion to common shares
 
8,898

 

 
4,474

 

Diluted weighted average common shares outstanding (1)
 
459,436

 
398,478

 
454,923

 
398,398

Diluted EPS
 
$
0.20

 
$
0.17

 
$
0.38

 
$
0.36



(1)
At June 30, 2019, the Company had approximately 2.4 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and six months ended June 30, 2019, as their inclusion would have been anti-dilutive.  These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $7.42. These equity instruments may have a dilutive impact on future EPS.  

During the three and six months ended June 30, 2019, the Convertible Senior Notes were determined to be dilutive and were included in the calculation of diluted EPS under the “if-converted” method. Under this method, the periodic interest expense for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether the conversion option is in or out of the money) are included in the denominator for the purpose of calculating diluted EPS.